Back to top

Reckitt Benckiser beats top-line and bottom-line estimates; reaffirms FY26 outlook

Reckitt Benckiser beats top-line and bottom-line estimates; reaffirms FY26 outlook

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Reckitt Benckiser Group PLC (RBGLY)